- UniDoc Health (CSE:UDOC) has surpassed one million patient visits through UniDoc Connect, its enterprise eHealth platform.
- The company develops remote healthcare solutions for populations challenged by distance, access, technology use or care availability.
- UniDoc Health stock last traded at C$0.09 and has given back 64 per cent year-over-year.
UniDoc Health (CSE:UDOC), a technology company disrupting the healthcare industry with its virtual clinic model, has surpassed one million patient visits through its UniDoc Connect enterprise eHealth platform, with more than 740,000 visits recorded between September 2025 and April 2026.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
UniDoc Connect specializes in remote clinical workflows, supporting medical device data, documents, medical images and live video to meet the needs of healthcare organizations across diversified care settings.
The milestone, catalyzed by the March 2025 acquisition of AGNES Connect and AMD Telemedicine, while representing recorded platform visits, as opposed to unique patients, nevertheless affords the company a key gauge for ongoing growth through new organic customer acquisition and AMD customer integration, which it intends to integrate into future discussions with clinics, health systems, governments and other potential partners.
According to a May 21st news release, UniDoc Connect’s presence stretches across more than 800 sites in 48 countries, supported by integrations with more than 400 medical devices, granting it an estimated annual revenue run rate above the seven-figure threshold.
Leadership commentary
“Reaching one million recorded patient visits is a clear marker for UniDoc,” Tony Baldassarre, Chief Executive Officer of UniDoc Health, said in Tuesday’s news release. “Increasing from around a quarter of a million visits in the first half of the year to over one million visits in the second half shows a substantial growth in patient visits. We believe this growth has come from two places – the first being from new customers and the second from our efforts in working with existing customers that came to UniDoc through the AMD purchase to help them better utilize their systems. That is the operating plan: Bring customers onto the platform, support them and turn installed systems into active clinical workflows.”
About UniDoc Health
UniDoc develops remote healthcare solutions, including software, diagnostic devices and communications tools, for populations challenged by distance, access, technology use or care availability.
UniDoc Health stock (CSE:UDOC) last traded at C$0.09 and has given back 64 per cent year-over-year.
Join the discussion: Find out what investors are saying about this micro-cap healthcare technology stock on the UniDoc Health Corp. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.
